Respiratory syncytial virus infection in children with severe motor and intellectual disabilities

S Onoyama1, T Hoshina, S Honjo

  • 1Department of Pediatrics, Graduate School of Medical Sciences, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka, 812-8582, Japan.

Insights

Children with severe motor intellectual disabilities (SMID) face higher risks from respiratory syncytial virus (RSV) lower respiratory tract infections (LRTI). These children require improved prevention and treatment strategies for RSV infections.

Area of Science:

  • Pediatric Infectious Diseases
  • Neurology
  • Respiratory Medicine

Background:

  • Children with severe motor intellectual disabilities (SMID) are a vulnerable population with increased mortality risk from acute viral lower respiratory tract infections (LRTI).
  • Respiratory syncytial virus (RSV) is a primary cause of viral LRTI in children, yet its specific impact on children with SMID requires further investigation.

Purpose of the Study:

  • To evaluate the influence and clinical outcomes of RSV-LRTI in children diagnosed with SMID.
  • To compare the clinical presentation and laboratory findings of RSV-LRTI between children with and without SMID.

Main Methods:

  • A case-control study was conducted over five RSV seasons, comparing 18 children with SMID to 43 previously healthy children hospitalized for RSV-LRTI.
  • Clinical data and laboratory results were analyzed to identify differences between the SMID and non-SMID groups.

Main Results:

  • Children with SMID were older upon hospitalization and showed an increased need for ventilation support.
  • The SMID group exhibited significantly higher neutrophil counts and a lower incidence of bacterial co-infection.
  • SMID was independently associated with prolonged oxygen use (OR 5.309, p=0.033), indicating a higher risk of hypoxia.

Conclusions:

  • Children with SMID are particularly susceptible to developing hypoxia due to RSV-LRTI.
  • Current treatment and prevention strategies for RSV infection necessitate enhancement for the SMID pediatric population.

Related Concept Videos

Intellectual Disability01:29

Intellectual Disability

Intellectual disability (ID) is a neurodevelopmental condition characterized by deficits in intellectual and adaptive functioning that manifest during the developmental period. This condition encompasses challenges in reasoning, memory, problem-solving, and learning, accompanied by impairments in everyday life skills, such as communication, self-care, and social interactions. Intellectual disability affects approximately 1% of the population in the United States, impacting an estimated 5...
Common Respiratory Disorders01:31

Common Respiratory Disorders

Respiratory disorders, a prevalent health concern globally, are generally divided into two primary categories: upper and lower respiratory tract disorders. The categorization is based on the area of the respiratory system they affect.
Upper respiratory disorders impact the airways above the vocal cords, encompassing areas like the nose, sinuses, and throat. Various conditions fall under this category, including the common cold and allergic rhinitis. These disorders can stem from several causes,...
Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
Acute Respiratory Failure-V01:29

Acute Respiratory Failure-V

The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...